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Abstract
Background—Pathophysiological models of bipolar disorder postulate that mood dysregulation
arises from fronto-limbic dysfunction, marked by reduced prefrontal cortex (PFC) inhibitory
control. This may occur both due to disruptions within PFC networks and abnormal inhibition
over subcortical structures involved in emotional processing. However, no study has examined
global PFC dysconnectivity in bipolar disorder and tested if regions with within-PFC
dysconnectivity also exhibit fronto-limbic connectivity deficits. Further, no study has investigated
whether such connectivity disruptions differ for bipolar patients with psychosis history, who may
exhibit a more severe clinical course.
Methods—We collected resting-state fMRI at 3T in 68 remitted bipolar I patients (34 with
psychosis history) and 51 demographically-matched healthy participants. We employed a recently
developed Global Brain Connectivity method, restricted to PFC (rGBC). We also independently
tested connectivity between anatomically-defined amygdala and PFC.
Results—Bipolar patients exhibited reduced medial PFC (mPFC) rGBC, increased amygdala-
MPFC connectivity, and reduced connectivity between amygdala and dorso-lateral PFC. All
effects were driven by psychosis history. Moreover, the magnitude of observed effects was
significantly associated with lifetime psychotic symptom severity.
Conclusions—This convergence between rGBC, seed-based amygdala findings and symptom
severity analyses highlights that mPFC, a core emotion regulation region, exhibits both within-
PFC dysconnectivity and connectivity abnormalities with limbic structures in bipolar illness.
Furthermore, lateral PFC dysconnectivity in patients with psychosis history converges with
published work in schizophrenia, indicating possible shared risk factors. Observed dysconnectivity
in remitted patients suggests a bipolar trait characteristic and may constitute a risk factor for
phasic features of the disorder.
Keywords
bipolar disorder; prefrontal cortex; amygdala; connectivity; resting-state; psychosis
Introduction
Bipolar disorder is characterized by prominent mood dysregulation(1). Pathophysiological
models of bipolar illness suggest this dysregulation may arise from both dysfunction in
prefrontal cortical (PFC) networks linked to cognitive control of emotion, and disruptions in
prefrontal control over subcortical regions involved in affective processing like the
amygdaloid complex(2). Functional magnetic resonance imaging (fMRI) findings support
this model by demonstrating abnormalities across subcortical/limbic and cortical structures,
notably the amygdala and medial PFC (mPFC)(3). These regions show mood-state-
dependent activity alterations in bipolar disorder and have been linked to emotion generation
and appraisal(4–7). Moreover, individuals with bipolar disorder show aberrant prefrontal
activation across cognitive challenges(6, 8), suggesting possible disturbances in prefrontal
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function. However, PFC is large and heterogeneous with widespread connectivity and it is
unclear which specific prefrontal circuits may be compromised in this disorder. While
evidence supports that localized structure and function of mPFC is disrupted in bipolar
disorder(8), there is relatively little information about the relationships between prefrontal
cortical regions in bipolar illness. Complex neuropsychiatric disease like bipolar disorder
may result from disrupted neural computations across networks of regions(9). Indeed, severe
mood disorders are associated with abnormal structural plasticity and cellular resilience(10–
12), which may give rise to impairments in distributed neural networks(9). Therefore, it is
critical to identify prefrontal circuitry exhibiting distributed PFC functional abnormalities,
which may relate to deficits in both PFC function and control over limbic structures. Yet,
prefrontal dysconnectivity has not been systematically investigated in this illness.
A growing body of evidence shows that distributed neural circuits exhibit spontaneous
activity at rest(13). These slow-frequency fluctuations are temporally correlated within
spatially-distinct but functionally-related networks(14), establishing an intrinsic functional
network architecture (15) across primate species(16). These networks show high
concordance with other measures of structural and functional connectivity in healthy
populations(17) and provide an opportunity to characterize distributed circuit abnormalities
in neuropsychiatric illnesses(18). Prior research using resting-state techniques demonstrates
that individuals with bipolar disorder show reduced connectivity within the “default mode
network”(19), the pregenual anterior cingulate, thalamus and amygdala(20), as well as in the
ventral prefrontal-amygdala pathways(21). Although these findings constitute important
advances in our understanding of bipolar disorder, no study to date has investigated global
prefrontal dysconnectivity patterns (i.e. across all prefrontal gray matter voxels). Such a
global, data-driven approach is vital as it allows comprehensive examination of prefrontal
connectivity abnormalities. This in turn offers the potential to identify specific prefrontal
nodes compromised in bipolar illness, which may also relate to regulation of limbic circuits.
Although identifying global prefrontal network disruption in bipolar illness is critical, such
findings do not imply fronto-limbic dysconnectivity. To establish fronto-limbic
dysconnectivity, both prefrontal and limbic connectivity must be assessed in the same
subjects. It is well recognized that amygdala shares dense connectivity with prefrontal
cortex, most notably caudal orbitofrontal cortex, mPFC and anterior cingulate gyrus(22–25)
– all regions implicated in regulation of emotion (among other functions). The critical point
of such analyses is to independently test if the same (or similar) regions identified via global
connectivity may also exhibit connectivity disturbances with the amygdala. That is,
examining deficits in limbic connectivity with broad PFC circuits is key to fully characterize
deficits in fronto-limbic dysregulation in bipolar disorder.
While we discussed bipolar disorder as a diagnostic category, bipolar illness is highly
heterogeneous in terms of onset, symptom severity, co-morbidity, clinical course, and
outcome. Such diversity implies that distinct, yet partially overlapping neurobiological
mechanisms may be involved in patients with differing clinical presentations. Capitalizing
on a dimensional approach(26) we can identify subpopulations of patients with common
symptoms or illness-course who may exhibit shared neural dysfunction. One potential axis
upon which to subdivide bipolar disorder is the presence or absence of psychotic symptoms.
Psychotic symptoms are present in 50–70% of individuals with bipolar disorder(27, 28) and
psychosis aggregates within families of bipolar patients(29). Lifetime history of psychosis
may represent a more severe form of the illness associated with poorer prognosis((30, 31);
but see(32)), cognitive performance(33), brain structure(34) and function(35). Recent
reports of global prefrontal dysconnectivity in schizophrenia(36) raises the intriguing
hypothesis that history of psychosis in bipolar disorder may be associated with more severe
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patterns of prefrontal dysconnectivity. However, prefrontal dysconnectivity has yet to be
examined in psychotic bipolar disorder.
Our goal was to investigate prefrontal-limbic dysconnectivity in bipolar disorder. We tested
three hypotheses: First, we examined whether there are global PFC connectivity
abnormalities in this illness by applying a recently developed global brain connectivity
method(37–39), which may particularly manifest in mPFC. Second, we compared patients
with a history of psychosis versus patients without psychosis to determine if psychotic
patients exhibit more severe PFC dysconnectivity, similar to findings in schizophrenia(36).
Third, we examined functional connectivity between the amygdala and PFC using
independent anatomically-delineated seeds. We specifically tested whether regions showing
global prefrontal disturbances exhibit convergence with amygdala dysconnectivity.
Methods
Participants
Participants provided informed consent approved by the IRB at Hartford Hospital and Yale
University. Sixty-eight remitted patients with bipolar I disorder and 51 demographically-
matched healthy individuals participated in the study (Table 1). Patients were identified
through outpatient clinics and community mental health facilities in the Hartford area.
Inclusion criteria for patients were: i) bipolar I disorder diagnosis as determined by the
Structured Clinical Interview (SCID) for the Diagnostic and Statistical Manual of Mental
Disorders-IV (DSM-IV)(40), administered by experienced MA or PhD-level research
clinicians; ii) no history of major medical or neurological conditions (e.g. epilepsy,
migraine, head trauma with loss of consciousness); and iii) IQ>80 assessed by Wechsler
Abbreviated Intelligence Scale(41). To increase ecological validity of the patient sample, co-
morbid Axis I anxiety disorders and/or history of substance abuse (fully remitted >6 months
prior to the study) were allowed. Healthy participants were recruited through media
advertisements and flyers posted in the Medical Center area. Inclusion criteria for healthy
participants were: i) no current or lifetime Axis I psychiatric disorder as assessed by SCID-
NP; ii) no history of medical or neurological conditions; and iii) no history of psychotic or
mood disorders in first-degree relatives (reported by detailed family history). While groups
were matched for age, ethnicity, and sex, healthy participants’ education attainment was
greater than that of patients with bipolar disorder (p=.01)(42). Education differences are
impacted by the illness course(43) and thus were not included as a covariate; alcohol, drug
use, anxiety, age, illness duration, gender and medication type did not alter reported effects.
Current Symptoms & Medication
Severity of current mood symptoms was determined with the 21-item Hamilton Depression
scale (HAM-D)(44), the Young Mania Rating Scale (YMRS)(45), and the expanded version
of the Brief Psychiatric Rating Scale (BPRS)(46). Only remitted patients were included in
the current experiment (>1 week), defined using standardized cutoffs on the HAM-D (less
than or equal to 7) and YMRS (less than or equal to 7) (Table 1). 53% of bipolar patients
were receiving mood stabilizers, 43% were taking antidepressants, 34% were taking atypical
antipsychotics, 35% were taking anxiolytics, 16% were on lithium, and 16% were un-
medicated at the time of assessment (note: some patients were on multiple medications). As
noted, reported effects were not altered when we co-varied for medication. For details on
psychosis history evaluation for bipolar patients with psychosis (BPP) vs. those without
psychosis (BWP) see Supplement.
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Complete fMRI acquisition and preprocessing details are presented in the Supplement. The
global brain connectivity (GBC) approach(36, 38) was applied using in-house Matlab tools.
GBC estimates the connectivity between each individual voxel and every other voxel in the
brain. In contrast, restricted GBC estimates connectivity at every voxel with every other
voxel in a restricted space (referred to hereafter as restricted global brain connectivity -
rGBC). Here we conducted rGBC analysis restricted to voxels within subject-specific
Freesurfer-based(47) prefrontal gray matter masks (see Supplement for FreeSurfer
segmentations that comprised the mask). To account for between-subject differences in
anatomy, before the analysis, BOLD signal within the subject-specific cortical mask was
spatially smoothed with a 6mm full-width-at-half-maximum (FWHM) Gaussian kernel and
dilated by two voxels (6mm) to account for individual differences in anatomy. Following
our prior work(36), the rGBC analysis involved, for each PFC voxel, computing a
correlation with every other PFC voxel, transforming the correlations to Fisher z-values, and
computing the mean. This yielded a map for each subject where each voxel value represents
the mean connectivity of that voxel with the rest of PFC.
Amygdala Seed-based Functional Connectivity (fcMRI) Analysis
The seed-based amygdala fcMRI closely followed our prior work(48). As with rGBC, we
employed in-house Matlab tools(49, 50) to examine the relationship between amygdala and
all PFC voxels. To this end, we computed a seed-based amygdala correlation map by
extracting average time-series across all voxels in each subject’s bilateral amygdala
(anatomically defined through Freesurfer-based segmentation(47, 51)), which was then
correlated with each PFC voxel. Next, as with rGBC, we computed a Fisher r-to-Z
transform, which yielded a map for each subject where each PFC voxel value represents
connectivity with the amygdala.
2nd-Level Group Analysis
Before computing group-level statistics, individual amygdala fcMRI and rGBC correlation
maps were converted to Fisher-Z maps. To examine hypothesized between-group
differences, these maps were entered into 1-way ANOVAs with three across-group levels
(controls, BPP, BPW). Both analyses were corrected within the anatomically-defined PFC
mask (95% overlap across all subjects). Type I error correction was based on peak and
cluster extent(52) ascertained via AFNI’s AlphaSim with exact smoothness estimates
computed from the general linear model residuals (p<.001, k=14 voxels for rGBC and k=13
for amygdala fcMRI). Results were visualized using Caret 5.5 software (http://
brainvis.wustl.edu/wiki/index.php/Caret).
Results
Global Prefrontal Connectivity in Bipolar Disorder
To test hypothesized between-group difference in rGBC we computed a 1-way ANOVA.
Results revealed a significant Group effect centered on mPFC (x=3, y=32, z=1) (Figure 1A).
This effect was largely driven by reduced connectivity for bipolar patients with psychosis
history. Notably, healthy participants did not exhibit any regions of reduced prefrontal
connectivity relative to the bipolar group, despite virtually identical SNR. To confirm that a
history of psychosis is associated with more severe prefrontal dysconnectivity, we computed
two follow-up independent-sample t-tests. Patients with psychosis history showed lower
mPFC rGBC compared to healthy controls [t(83)=4.31, p<.001], and when compared to
bipolar patients without psychosis history [t(66)=3.51, p<.001] (Figure 1B). Pair-wise
comparisons were also significant when corrected within the PFC mask as a whole,
Anticevic et al. Page 5













illustrating the robustness of this effect. We also present a direct comparison of controls vs.
the entire sample of bipolar patients for qualitative inspection in the Supplement (Figure
S1).
Amygdala-Prefrontal Connectivity in Bipolar Disorder
To circumvent region selection bias and to ensure complete independence from observed
rGBC effects (see Supplement for more detailed independence considerations), we
computed a separate anatomically defined amygdala seed-based analysis with PFC, and
examined the main effect of Group in a 1-way ANOVA. If we were to seed from the mPFC
and indeed identify differences centered around the amygdala one could raise the issue of
circularity (as those functional voxels were defined using the present analysis)(53). Results
revealed two foci showing significant between-group effects (Figure 2A–B): centered on
mPFC (x=1, y=41, z=−3) and right dorso-lateral PFC (DLPFC) (x=34, y=43, z=30). Again,
amygdala-mPFC findings were predominantly driven by bipolar patients with psychosis
history. However, in contrast to rGBC effects, patients with psychosis history showed focal
increased connectivity between the amygdala and mPFC relative to healthy controls
[t(83)=4.5, p<.001] and relative to bipolar patients without psychosis [t(66)=2.76, p<.007]
(Figure 2A). Conversely, for the amygdala-DLPFC region, bipolar patients with psychosis
history evidenced more negative connectivity relative to controls [t(83)=4.62, p<.001] and
patients without psychosis history [t(66)=4.11, p<.001] (Figure 2B). To allow complete
interpretation of amygdala findings we present threshold-free patterns for controls and
bipolar patients in the Supplement (Figure S2).
Testing for Convergence of rGBC and Amygdala Connectivity Effects
Given our questions regarding both frontal and limbic dysconnectivity, we tested whether
the voxels identified through a given analysis showed convergent effects with the other
analysis. That is, given complete independence of identified regions, we tested rGBC effects
in the mPFC voxels identified via amygdala connectivity and vice versa (i.e. amygdala
connectivity effects in the mPFC voxels identified via rGBC). The purpose of the
convergence analysis was to test whether identified voxels across the two approaches
represent functionally distinct regions. Both effects converged: i) the rGBC effect remained
significant and consistent in the mPFC region identified via amygdala connectivity
[F(2,116)=6.8, p<.002]; ii) the amygdala-mPFC effect remained significant and consistent in
the mPFC region identified via rGBC analysis [F(2,116)=3, p=.05]. Together, these findings
further argue that functionally similar effects were present for both analyses across
independently identified mPFC voxels.
Lifetime Psychotic Symptom Severity
To additionally examine the association between observed dysconnectivity and psychosis,
we correlated measures of lifetime psychotic symptoms derived using the Lifetime
Dimensions of Psychosis Scale (LDPS) (see Supplement) with regions that revealed
between-group effects. We computed a Spearman’s correlation coefficient due to non-
normally distributed symptom scores (i.e. some patients had no psychotic symptoms). We
focused on positive symptoms because few patients reported lifetime negative/
disorganization symptoms. There was an inverse relationship between severity of lifetime
positive symptoms and mPFC rGBC [rho=−.22, p=.07, trend] indicating that patients with
more severe lifetime positive psychotic symptoms (e.g. hallucinations and delusions) exhibit
even lower mPFC rGBC (Figure 3A). In contrast, elevated amygdala-mPFC coupling was
associated with increased lifetime psychotic symptom severity [rho=.31, p<.015] (Figure
3B), whereas lower amygdala-DLPFC coupling was associated with more severe symptoms
[rho=−.44, p<.0001] (Figure 3C). We carried out further sub-group analysis with only those
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patients exhibiting psychotic symptoms (N=50, see Supplement), which revealed a
consistent, but attenuated pattern.
Discussion
We investigated PFC connectivity in bipolar I disorder and found, consistent with
predictions: i) significant between-group differences in mPFC rGBC, particularly prominent
for patients with psychosis history compared to those without and controls; ii) increased
connectivity for amygdala-mPFC and lower connectivity for amygdala-DLPFC networks in
bipolar patients relative to controls that was exaggerated in patients with psychosis history;
and iii) that the magnitude of observed effects scaled with lifetime symptom severity. These
findings provide evidence for distributed dysconnectivity between mPFC and other
prefrontal regions and focal fronto-limbic dysconnectivity between mPFC and amygdala.
Global Prefrontal and Fronto-Limbic Connectivity
We hypothesized that bipolar patients would exhibit global prefrontal dysconnectivity in
regions associated with affect regulation, such as mPFC, based on prior work indicating
their critical role in regulating emotion(24). Consistent with predictions, we identified a
focal mPFC region for which patients showed reduced connectivity relative to healthy
controls. These regional findings are highly consistent with both meta-analytic and seed-
based neuroimaging studies reporting focal differences in bipolar disorder(6, 54). However,
this is the first investigation to directly document reduced functional integration between
mPFC with the rest of prefrontal cortex in bipolar disorder. Present findings illustrate that
widespread prefrontal functional disruptions with mPFC may underlie risk for affect
deregulation, which constitutes the hallmark symptom of this illness (as patients were
euthymic at the time of the scan and therefore observed differences cannot be attributed to
present affect regulation deficits). Interestingly, this region showed reduced global
prefrontal connectivity in patients with psychosis history relative to other groups (discussed
below).
As noted, mPFC is involved in regulation of affect through dense and reciprocal
connectivity with subcortical regions implicated in generation of affective states (e.g.
amygdala)(22). Yet, the rGBC analysis does not guarantee that identified regions exhibit
deficits in regulation of limbic circuits. That is, the rGBC analysis included prefrontal
cortex, not subcortical limbic regions, leaving open the possibility that the mPFC region
identified as showing lower prefrontal connectivity might independently show reduced
subcortical limbic connectivity. Thus, we examined potential convergence between rGBC
and seed-based amygdala-PFC connectivity. Our independent amygdala analysis revealed a
region in close proximity to the rGBC effect (although not precisely overlapping) –
indicating that similar cortical territories that exhibit reduced PFC integration may also be
involved in reduced limbic regulation in bipolar illness. Moreover, when we tested for
convergence of effects across analysis (given their statistical independence), we found
highly similar results across both identified regions. Present findings further solidify –
through two independent but convergent approaches – that mPFC plays a critical role in the
pathophysiology of bipolar illness.
Previous resting-state studies in humans and tracing studies in primates have shown that a
portion of the medial PFC exhibits positive connectivity with the amygdala(22, 24, 25, 55–
58), which we observed in our prior work(48) and here (threshold-free amygdala maps
shown in Supplement). In Figure 2A the identified mPFC region exhibits low connectivity
with amygdala in controls, which is increased in patients. Therefore, what does it mean if
connectivity exists in a patient population that is ‘low’ in healthy subjects? It has been well-
established that functional connectivity is dynamic and state-dependent(59) whereby a low
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resting-state value may change and become more positive during times when emotional
regulation is warranted. Thus, the observed increased values in bipolar illness may reflect a
‘state’ that exists due to a heightened need for mood regulation (as proposed in the context
of fear extinction,(60)). There is also the possibility that the connection ‘weight’ changes
from frequent attempts to regulate mood. In other words, patients may be in a different state
in day-to-day life frequently enough that resting amygdala-mPFC connectivity has altered
(in a Hebbian sense)(59). We acknowledge that these hypotheses are speculative, yet they
highlight scenarios where low coupling in the normative sample, but an increase in the
clinical sample, may reflect a meaningful disturbance in amygdala-mPFC connectivity.
Further work is needed to verify these possibilities. In addition, we opted for a PFC-wide
amygdala seed-based analysis (as opposed to a restricted one) to verify whether amygdala
seed-based results converge with those identified via rGBC (which may occur in places
outside of functionally restricted patterns). Therefore, future studies should additionally
constrain analyses to the medial PFC showing significant connectivity with the amygdala in
healthy subjects (to add further power).
Lastly, given present focal findings, one direction that may further elucidate the
pathophysiology of bipolar illness, is to relate observed dysconnectivity patterns that are
predictive of symptoms with spatial patterns of gene expression known to affect cortical
development(61). Recent advances in transcriptomics offer a quantitative approach toward
characterizing the transcriptional landscape of PFC. Relating these spatial gene expression
maps to fMRI offers ways to constrain our search for genes that exhibit expression in areas
showing functional abnormalities with our neuroimaging markers. We acknowledge that
bipolar illness is not exclusively genetic, but rather that indexes of dysconnectivity derived
using novel measures could be employed to track spatio-temporal expression of genes that
confer risk for development of bipolar illness.
Prefrontal Dysconnectivity and Psychosis
We examined the association between psychotic symptoms and prefrontal dysconnectivity
in three ways: i) comparison of psychotic bipolar patients with controls; ii) comparison of
patients with and without a history of psychosis; and iii) examination of lifetime history of
psychosis severity and prefrontal dysconnectivity. All three comparisons indicated that
psychotic bipolar patients exhibit a more severe pattern of mPFC rGBC and amygdala-
mPFC/DLPFC coupling, further highlighted by individual-difference analyses. Interestingly,
there was a mirror-like pattern between mPFC rGBC and amygdala-mPFC coupling,
possibly reflecting reduced within-PFC integration, but higher connectivity due to
compensatory regulation over the amygdala (previously reported for mPFC-insula
coupling(54)). Importantly, given that patients were asymptomatic at the time of assessment,
our findings support the notion that observed dysconnectivity constitutes a trait-like feature
and may be related to illness risk and relapse vulnerability rather than current psychotic
symptom expression. Thus, mPFC dysconnectivity may be a marker for disease risk, a
possibility worth examining in at-risk or prodromal populations.
These results also extend prior findings of reduced prefrontal connectivity in schizophrenia,
which were centered on right DLPFC and left inferior frontal junction(36). Although present
rGBC analysis in bipolar illness only identified mPFC dysconnectivity, we found reduced
amygdala-DLPFC connectivity in bipolar disorder that was particularly associated with
psychosis. In contrast, higher amygdala-mPFC connectivity was present even in patients
without psychosis history. One possibility is that while mPFC dysconnectivity may
constitute a risk factor for bipolar disorder more generally, lateral prefrontal dysfunction
may be particularly associated with risk for psychotic symptoms. Thus, present results
suggest a two-part hypothesis whereby different aspects of frontal dysconnectivity may be
responsible for psychosis vs. mood instability(62, 63). One possibility is that psychosis and
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mood instability may arise due to separate processes that overlap in their anatomy and may
be inherited together through distinct vulnerabilities combining via mechanisms such as
assortative mating to yield psychotic bipolar illness. An alternative possibility is that these
apparently separate clinical illnesses represent different phenomenological expressions of
the same underlying problem at a neural circuit level, consistent with the proposal suggested
by the Research Domain Criteria (RDoC) initiative(26).
Future studies should further delineate common and unique aspects of neuropathology
underlying these co-morbid but distinct symptom presentations. Current findings illustrate
the need for a direct comparison of clinical groups presenting with psychotic symptoms, but
possibly uniquely different aspects of cortical neuropathology. A complicating factor
between investigations is psychotic illness duration/severity and its effect on prefrontal
cortical circuits. It is possible that illness duration differentially impacts patterns of cortical
connectivity. Similarly, acute psychotic states may be marked by a distinct pattern of
prefrontal connectivity disruptions than those found in chronic patients(64). Thus, future
work should quantify differences in prefrontal rGBC/fcMRI in psychotic illness that may
relate to time, severity, and co-morbidity. Such an approach, capitalizing on GBC’s data-
driven advantages and ability to deal with individual differences in connectivity
patterns(36), may provide a tool for linking patterns of prefrontal dysconnectivity with
psychotic illness heterogeneity.
Limitations
Present findings should be interpreted within the confines of several limitations. First, we
allowed for co-morbid anxiety and history of drug/alcohol abuse/dependence to obtain a
more ecologically-valid sample (although effects remain unchanged when we co-varied for
these variables). Future studies should delineate to what extent present results replicate when
examining subgroups with and without such co-morbid diagnoses. Second, patients were
remitted (2 weeks) and we examined findings as a function of psychotic history. An
important future direction is to examine the extent to which these patterns hold as severity of
psychosis increases during mood episodes and to fully role out the possibility that
differences in symptoms may reflect general psychopathology rather than psychosis history
per se. Third, due to correlational nature of the analyses, it is unclear whether changes in
connectivity reflect the cause of the mood disturbance versus the consequence of the illness.
Thus, it will be critical to examine if connectivity patterns relate to illness duration, number
of episodes and/or frequency of cycling, and manifest in at-risk populations. Fourth, despite
convergence, the rGBC/seed-based findings are exploratory, given the voxel-wise search for
prefrontal dysconnectivity and should also be verified using an independent replication.
Similarly, it will be important to verify amgydala findings using identified mPFC and
DLPFC as seeds via an independent sample (to ensure region selection independence(53)).
This also applies to the individual difference analyses, which are not completely orthogonal
to the originally presented results (thought they add convergent effects). Fifth, there is likely
to be further functional specialization within the amygdala itself that we currently cannot
capture in our study(65), which should be examined prospectively. Lastly, although when
used as covariates medications did not alter the reported effects, reported patterns should be
replicated in unmedicated samples(66).
Conclusion
Current findings substantially extend prior work in bipolar illness using a recently developed
tool designed to detect global disruptions in prefrontal connectivity, applied to a well-
powered sample with carefully matched across-group demographics and SNR. We found
reduced mPFC connectivity with the rest of PFC in bipolar disorder – a pattern that was
inversely correlated with psychosis history. Critically, an independent amygdala seed-based
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analysis revealed elevated connectivity with a highly proximal mPFC region. These
convergent yet independent effects highlight that mPFC dysconnectivity may represent a
potential trait characteristic or risk factor of the disorder. Furthermore, given that the
observed pattern of prefrontal dysconnectivity varied as a function of psychosis history
(similar to findings in schizophrenia) suggests that disrupted PFC connectivity may be
important for development of psychosis trans-diagnostically. Overall, our convergent
findings suggest that disruption of prefrontal/limbic networks, particularly mPFC, may be a
possible biomarker for bipolar disease risk.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Global Prefrontal Dysconnectivity
(a) Significant between-group differences in prefrontal rGBC between bipolar patients and
healthy participants revealed a medial prefrontal cortex region (MPFC) (x=3, y=32, z=1).
The red border approximately marks the restricted PFC analysis. (b) rGBC values are shown
for the mPFC region across the three groups; healthy participants (white) and bipolar
patients without psychosis history (BPW, gray); bipolar patients with history of psychosis
(BPP, black). Error bars represent +/− 1 standard error of the mean.
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Figure 2. Amygdala Prefrontal Dysconnectivity
Significant group differences in amygdala-prefrontal fcMRI between bipolar disorder
subgroups and healthy controls. (a) Yellow/red foci mark regions where bipolar patients
with a history of psychosis showed increased amygdala connectivity relative to non-
psychotic patients and healthy controls. This pattern was centered on the medial prefrontal
cortex (mPFC) (x=1, y=41, z=−3). The red border approximately marks the restricted PFC
analysis. (b) A right DLPFC region (x=34, y=43, z=30) is shown in blue for which bipolar
patients with a history of psychosis showed decreased amygdala connectivity relative to
non-psychotic patients and healthy controls. The rGBC values are shown across both foci
for controls (white), bipolar patients without a history of psychosis (BPW, grey) and bipolar
patients with history of psychosis (BPP, black). Error bars represent +/− 1 standard error of
the mean.
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Figure 3. rGBC, Amygdala-Prefrontal Dysconnectivity and Lifetime Psychotic Symptom
Severity
(a) Trend-level inverse relationship between mPFC rGBC and lifetime positive psychotic
symptom severity across the entire sample of bipolar patients (rho= −.22, p=.07). (b)
Significant positive relationship between amygdala-mPFC fcMRI and lifetime positive
psychotic symptom severity across the entire sample of bipolar patients (rho=.31, p<.015).
(c) Significant inverse relationship between amygdala-DLPFC fcMRI and lifetime positive
psychotic symptom severity across the entire sample of bipolar patients (rho= −.44, p<.
0001). Direction of all reported individual difference effects show strong convergence with
main effects. The scale on the x-axis captures a clinician-rated severity index that ranges
from 0 (absent) to 4 (Very severe; Gross or nearly constant effect on function) (67).
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